Status:

COMPLETED

MediBeat - HeartBeat Observation Trial

Lead Sponsor:

SE Health

Collaborating Sponsors:

Centre for Aging and Brain Health Innovation

Conditions:

Low Blood Pressure

Blood Pressure

Eligibility:

All Genders

25+ years

Phase:

NA

Brief Summary

The goal of the study was to compare the current gold standard blood pressure instrument (a mercury-filled sphygmomanometer with cuff and stethoscope) with the new experimental algorithm developed by ...

Detailed Description

The gold standard instrument for blood pressure measurement is a mercury-filled sphygmomanometer with cuff and stethoscope (Canadian Agency for Drugs and Technologies in Health; Canadian Electronic Li...

Eligibility Criteria

Inclusion

  • adult over 25 years of age

Exclusion

  • those who have heart arrhythmias,
  • atrial fibrillations or atrial flutters,
  • an inaudible Korotkoff sound,
  • wounds of the upper arms/wrists, missing fingers, and/or
  • an arm circumference of more than 55 cm will be excluded

Key Trial Info

Start Date :

October 4 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 17 2019

Estimated Enrollment :

94 Patients enrolled

Trial Details

Trial ID

NCT04082819

Start Date

October 4 2019

End Date

December 17 2019

Last Update

April 1 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

SE Health

Markham, Ontario, Canada, L3R 6H3